Fortis Healthcare Stock Hits All-Time High Ahead of Q1 Results

As of 7th August 2025,

stock rallied strongly ahead of its Q1 results, with investors cheering a robust 53% year-on-year jump in net profit. The stock surged as much as 5.4% intraday to mark a new all-time high of ₹904.5, before closing with a healthy gain of 3%. Fortis Healthcare has delivered a stellar performance so far in calendar year 2025, gaining 22.80% YTD. Looking at its annual returns since 2020, the stock has posted: 17.66% (2020), 91.56% (2021), -3.77% (2022), 46.52% (2023), and 71.72% (2024). This impressive trajectory translates into a CAGR of nearly 40% over the last 5 years and 7 months, underlining its consistent growth and investor confidence. With strong fundamentals and earnings momentum, Fortis Healthcare remains one of the top performers in the healthcare sector. Disclaimer: This document is prepared by SEBI RRA (Reg. No. INH000016649), solely for informational purposes. It does not constitute investment advice, trading recommendations, or an offer to buy/sell any securities. Information is based on sources deemed reliable but is not guaranteed for accuracy or completeness. No warranty, express or implied, is provided. Portions of this content may have been reviewed or refined using AI tools to enhance grammatical accuracy and sentence structure. Past performance is not indicative of future results. Investments are subject to market risks. Investors should consult a qualified financial advisor before making decisions. SEBI registration and NISM certification do not assure performance or returns. Any securities mentioned, if any, are purely illustrative and not recommendations.